As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/27/16  Select Medical Corp               8-K:5       4/25/16    1:46K                                    Merrill Corp-MD/FA
          Select Medical Holdings Corp

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     31K 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  April 25, 2016

 

 

SELECT MEDICAL HOLDINGS CORPORATION
SELECT MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

4714 Gettysburg Road, P.O. Box 2034

Mechanicsburg, PA 17055

(Address of principal executive offices)  (Zip Code)

 

(717) 972-1100

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o                                    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o                                    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o                                    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o                                    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 5.07                   Submission of Matters to a Vote of Security Holders.

 

The annual meeting of stockholders (the “Annual Meeting”) of Select Medical Holdings Corporation (the “Company”) was held on April 25, 2016.  At the Annual Meeting, the Company’s stockholders approved four proposals.  The proposals below are described in the Company’s definitive proxy statement dated March 3, 2016.  The results are as follows:

 

Proposal 1: The Election of Three Class I Directors to the Board of Directors

 

Name		Votes For		Votes Against		Abstentions		Broker Non-Votes
Russell L. Carson		119,059,777		1,746,279		16,306		5,129,033
James S. Ely III		118,880,881		1,924,806		16,675		5,129,033
William H. Frist		110,682,391		10,124,853		15,118		5,129,033

 

Proposal 2:  Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers

 

Votes For		Votes Against		Abstentions		Broker Non-Votes
102,119,756		18,039,495		663,111		5,129,033

 

Proposal 3:  Approval of the Select Medical Holdings Corporation 2016 Equity Incentive Plan

 

Votes For		Votes Against		Abstentions		Broker Non-Votes
117,851,277		2,945,849		25,236		5,129,033

 

Proposal 4:  Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2016

 

Votes For		Votes Against		Abstentions		Broker Non-Votes
125,419,095		497,930		34,370		0

 

2

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.

 

	SELECT MEDICAL HOLDINGS CORPORATION
	SELECT MEDICAL CORPORATION
Date: April 27, 2016	By:	/s/ Michael E. Tarvin
		Michael E. Tarvin
		Executive Vice President, General Counsel and Secretary

 

3